Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moises A Calderon

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
The Journal of Allergy and Clinical Immunology|December 3, 2014
Basophil expression of diamine oxidase: a novel biomarker of allergen immunotherapy responseMohamed H Shamji, Janice A Layhadi, Guy W Scadding, et al.
Clinical and Translational Allergy|February 20, 2013
Assessment of disease control in allergic rhinitisPascal Demoly, Moises A Calderon, Thomas Casale, et al.
Current Allergy and Asthma Reports|March 16, 2017
Allergen Immunotherapy Clinical Trial Outcomes and Design: Working Toward Harmonization of Methods and PrinciplesHarold S Nelson, Moises A Calderon, David I Bernstein, et al.
Allergy and Asthma Proceedings|July 3, 2017
A call to arms of specialty societies to review the WHO International Classification of Diseases, Eleventh Revision terms appropriate for the diseases they manage: The example of the Joint Allergy AcademiesLuciana K Tanno, Thomas Casale, Nikolaos G Papadopoulos, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 8, 2021
Real-life report of allergen immunotherapy management during the COVID-19 outbreak in France and SpainPablo Rodriguez Del Rio, Davide Caimmi, Pilar Rico, et al.
Journal of Immunological Methods|July 5, 2012
Optimisation of grass pollen nasal allergen challenge for assessment of clinical and immunological outcomesGuy W Scadding, Moises A Calderon, Virginia Bellido, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|April 11, 2018
Critical view of anaphylaxis epidemiology: open questions and new perspectivesLuciana Kase Tanno, Ana Luiza Bierrenbach, F Estelle R Simons, et al.
The World Allergy Organization Journal|July 10, 2023
CHOICE international survey: Clusters of allergen immunotherapy prescription from French and Spanish cohortsPablo Rodriguez Del Rio, Davide Caimmi, Pilar Rico Nieto, et al.
The Journal of Allergy and Clinical Immunology|November 5, 2015
Short-term subcutaneous grass pollen immunotherapy under the umbrella of anti-IL-4: A randomized controlled trialAdam M Chaker, Mohamed H Shamji, Florentina A Dumitru, et al.
JAMA|February 15, 2017
Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical TrialGuy W Scadding, Moises A Calderon, Mohamed H Shamji, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
The Journal of Allergy and Clinical Immunology|December 3, 2014
Basophil expression of diamine oxidase: a novel biomarker of allergen immunotherapy responseMohamed H Shamji, Janice A Layhadi, Guy W Scadding, et al.
Clinical and Translational Allergy|February 20, 2013
Assessment of disease control in allergic rhinitisPascal Demoly, Moises A Calderon, Thomas Casale, et al.
Current Allergy and Asthma Reports|March 16, 2017
Allergen Immunotherapy Clinical Trial Outcomes and Design: Working Toward Harmonization of Methods and PrinciplesHarold S Nelson, Moises A Calderon, David I Bernstein, et al.
Allergy and Asthma Proceedings|July 3, 2017
A call to arms of specialty societies to review the WHO International Classification of Diseases, Eleventh Revision terms appropriate for the diseases they manage: The example of the Joint Allergy AcademiesLuciana K Tanno, Thomas Casale, Nikolaos G Papadopoulos, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 8, 2021
Real-life report of allergen immunotherapy management during the COVID-19 outbreak in France and SpainPablo Rodriguez Del Rio, Davide Caimmi, Pilar Rico, et al.
Journal of Immunological Methods|July 5, 2012
Optimisation of grass pollen nasal allergen challenge for assessment of clinical and immunological outcomesGuy W Scadding, Moises A Calderon, Virginia Bellido, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|April 11, 2018
Critical view of anaphylaxis epidemiology: open questions and new perspectivesLuciana Kase Tanno, Ana Luiza Bierrenbach, F Estelle R Simons, et al.
The World Allergy Organization Journal|July 10, 2023
CHOICE international survey: Clusters of allergen immunotherapy prescription from French and Spanish cohortsPablo Rodriguez Del Rio, Davide Caimmi, Pilar Rico Nieto, et al.
The Journal of Allergy and Clinical Immunology|November 5, 2015
Short-term subcutaneous grass pollen immunotherapy under the umbrella of anti-IL-4: A randomized controlled trialAdam M Chaker, Mohamed H Shamji, Florentina A Dumitru, et al.
JAMA|February 15, 2017
Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical TrialGuy W Scadding, Moises A Calderon, Mohamed H Shamji, et al.
Pageof 6